BIOCRYST PHARMACEUTICALS, INC. Payments to Acquire Debt Securities, Available-for-sale
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Payments to Acquire Debt Securities, Available-for-sale of $135.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $135.63M, a 362.27% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $125.50M, a 217.50% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $58.63M, a 117.71% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $262.24M, a 1.70% decline from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $266.76M, a 48.14% decline from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $514.41M, a 110.58% increase from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $244.28M, a 2339.90% increase from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $135.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $135.63M 10-Q · filed 2026-08-05 | $261.14M derived: sum of 3 quarters · filed 2026-08-05 | $319.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $125.50M derived: sum of 2 quarters · filed 2026-05-06 | $184.14M derived: sum of 3 quarters · filed 2026-05-06 | $213.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $125.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $184.14M derived: sum of 2 quarters · filed 2026-02-26 | $213.48M derived: sum of 3 quarters · filed 2026-08-05 | $262.24M 10-K · filed 2026-02-26 |
| 2025-09-30 | $58.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $87.97M derived: sum of 2 quarters · filed 2026-08-05 | $136.74M 10-Q · filed 2025-11-04 | $176.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $29.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $78.10M 10-Q · filed 2026-08-05 | $117.63M derived: sum of 3 quarters · filed 2026-08-05 | $144.56M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $48.76M 10-Q · filed 2026-05-06 | $88.29M derived: sum of 2 quarters · filed 2026-05-06 | $115.22M derived: sum of 3 quarters · filed 2026-05-06 | $227.52M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $39.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $66.46M derived: sum of 2 quarters · filed 2026-02-26 | $178.75M derived: sum of 3 quarters · filed 2026-02-26 | $266.76M 10-K · filed 2026-02-26 |
| 2024-09-30 | $26.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $139.23M derived: sum of 2 quarters · filed 2025-11-04 | $227.24M 10-Q · filed 2025-11-04 | $384.22M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $112.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $200.30M 10-Q · filed 2025-08-05 | $357.29M derived: sum of 3 quarters · filed 2026-02-26 | $481.18M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $88.01M 10-Q · filed 2025-05-06 | $245.00M derived: sum of 2 quarters · filed 2026-02-26 | $368.89M derived: sum of 3 quarters · filed 2026-02-26 | $453.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $156.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $280.88M derived: sum of 2 quarters · filed 2026-02-26 | $365.77M derived: sum of 3 quarters · filed 2026-02-26 | $514.41M 10-K · filed 2026-02-26 |
| 2023-09-30 | $123.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $208.78M derived: sum of 2 quarters · filed 2024-11-05 | $357.42M 10-Q · filed 2024-11-05 | $357.42M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $84.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $233.53M 10-Q · filed 2024-08-06 | $233.53M derived: sum of 3 quarters · filed 2025-02-25 | $338.55M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $148.64M 10-Q · filed 2024-05-07 | $148.64M derived: sum of 2 quarters · filed 2025-02-25 | $253.66M derived: sum of 3 quarters · filed 2025-02-25 | $354.85M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $105.02M derived: sum of 2 quarters · filed 2025-02-25 | $206.22M derived: sum of 3 quarters · filed 2025-02-25 | $244.28M 10-K · filed 2025-02-25 |
| 2022-09-30 | $105.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $206.22M derived: sum of 2 quarters · filed 2023-11-08 | $244.28M 10-Q · filed 2023-11-08 | $254.29M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $101.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $139.26M 10-Q · filed 2023-08-07 | $149.27M derived: sum of 3 quarters · filed 2024-02-27 | $149.27M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $38.07M 10-Q · filed 2023-05-08 | $48.08M derived: sum of 2 quarters · filed 2024-02-27 | $48.08M derived: sum of 3 quarters · filed 2024-02-27 | $48.08M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $10.01M derived: sum of 2 quarters · filed 2024-02-27 | $10.01M derived: sum of 3 quarters · filed 2024-02-27 | $10.01M 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $34.38M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $34.38M derived: sum of 3 quarters · filed 2023-02-27 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $34.38M derived: sum of 2 quarters · filed 2023-02-27 | $49.82M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $34.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $49.82M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $15.44M 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $3.02M 10-K · filed 2022-02-28 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $3.02M 10-Q · filed 2020-11-06 | $22.47M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.02M 10-Q · filed 2020-08-07 | $22.47M derived: sum of 3 quarters · filed 2021-03-01 | $48.88M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $3.02M 10-Q · filed 2020-05-11 | $22.47M derived: sum of 2 quarters · filed 2021-03-01 | $48.88M derived: sum of 3 quarters · filed 2021-03-01 | $61.30M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $19.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $45.86M derived: sum of 2 quarters · filed 2021-03-01 | $58.29M derived: sum of 3 quarters · filed 2021-03-01 | $62.61M 10-K · filed 2021-03-01 |
| 2018-09-30 | $26.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $38.83M derived: sum of 2 quarters · filed 2019-11-08 | $43.16M 10-Q · filed 2019-11-08 | $111.37M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $12.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $16.75M 10-Q · filed 2019-08-08 | $84.97M derived: sum of 3 quarters · filed 2020-03-13 | $91.47M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $4.33M 10-Q · filed 2019-05-09 | $72.54M derived: sum of 2 quarters · filed 2020-03-13 | $79.04M derived: sum of 3 quarters · filed 2020-03-13 | |
| 2017-12-31 | $68.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $74.72M derived: sum of 2 quarters · filed 2020-03-13 | $107.79M 10-K · filed 2020-03-13 | |
| 2017-09-30 | $6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $39.57M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $33.07M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | $14.11M 10-K · filed 2019-03-14 | |||
| 2015-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $34.42M derived: sum of 2 quarters · filed 2018-03-12 | $50.45M derived: sum of 3 quarters · filed 2018-03-12 | $53.83M 10-K · filed 2018-03-12 |
| 2015-09-30 | $28.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $44.97M derived: sum of 2 quarters · filed 2016-11-08 | $48.34M 10-Q · filed 2016-11-08 | $106.37M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $16.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $19.41M 10-Q · filed 2016-08-08 | $77.43M derived: sum of 3 quarters · filed 2017-02-27 | $80.63M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $3.38M 10-Q · filed 2016-05-09 | $61.40M derived: sum of 2 quarters · filed 2017-02-27 | $64.60M derived: sum of 3 quarters · filed 2017-02-27 | $67.89M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $58.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $61.22M derived: sum of 2 quarters · filed 2017-02-27 | $64.51M derived: sum of 3 quarters · filed 2017-02-27 | $73.88M 10-K · filed 2017-02-27 |
| 2014-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $6.49M derived: sum of 2 quarters · filed 2015-11-06 | $15.85M 10-Q · filed 2015-11-06 | $24.59M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $12.65M 10-Q · filed 2015-08-07 | $21.39M derived: sum of 3 quarters · filed 2016-02-26 | $36.26M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $9.37M 10-Q · filed 2015-05-08 | $18.11M derived: sum of 2 quarters · filed 2016-02-26 | $32.97M derived: sum of 3 quarters · filed 2016-02-26 | |
| 2013-12-31 | $8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $23.61M derived: sum of 2 quarters · filed 2016-02-26 | $23.97M 10-K · filed 2016-02-26 | |
| 2013-09-30 | $14.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $15.23M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $369.00K 10-Q · filed 2014-08-08 | |||
| 2012-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.62M derived: sum of 2 quarters · filed 2015-03-02 | $12.49M derived: sum of 3 quarters · filed 2015-03-02 | $16.15M 10-K · filed 2015-03-02 |
| 2012-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $10.82M derived: sum of 2 quarters · filed 2013-11-08 | $14.49M 10-Q · filed 2013-11-08 | $23.22M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | $10.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $14.53M 10-Q · filed 2013-08-08 | $23.27M derived: sum of 3 quarters · filed 2014-03-10 | $32.36M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | $3.67M 10-Q · filed 2013-05-09 | $12.40M derived: sum of 2 quarters · filed 2014-03-10 | $21.49M derived: sum of 3 quarters · filed 2014-03-10 | |
| 2011-12-31 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $17.82M derived: sum of 2 quarters · filed 2014-03-10 | $45.50M 10-K · filed 2014-03-10 | |
| 2011-09-30 | $9.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $36.77M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $27.68M 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $26.43M derived: sum of 2 quarters · filed 2013-03-11 | $55.91M 10-K · filed 2013-03-11 | |
| 2010-09-30 | $20.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $50.09M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $29.48M 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |